Collective cell invasion behaviour can be modelled in an ECMmimetic co-culture system. To test ELI, we developed a method for measuring collective cell invasion into a lawn of stromal cells. The collective cell invasion into stroma is a complex process 15-17 . During infiltration and spread, invading cells interact with stroma, which modulates their invasive capacity while experiencing contact guidance from the underlying extracellular matrix (ECM) fibres 1, 18, 19 . On the basis of these considerations, we sought to mimic the stromal invasion process through a patterned
P lacental invasion into the maternal endometrium of the uterus shows substantial similarities to early cancer dissemination into stroma [1] [2] [3] [4] . These similarities have inspired the hypothesis of antagonistic pleiotropy 5, 6 . According to this hypothesis, trophoblasts evolved the capacity to invade the endometrium, leading to invasive placentation. These mechanisms can become reactivated in cancer cells, leading to a predisposition to metastasis. This implies that cancer malignancy should be limited to placental mammals where invasive placentation first evolved. This prediction, however, is inconsistent with the fact that opossums, with ancestrally noninvasive placenta 7, 8 , get invasive skin cancers 9 . Here, we explore an alternative scenario in which stromal cells of the uterus evolved to either resist or permit invasion, determining the outcome of placental invasiveness 9 .
The likelihood that the evolution of the stromal environment is driving the evolution of cancer malignancy is enhanced by the fact that the molecular mechanisms used by cancer cells to metastasize are shared with other biological processes. For instance, the mechanisms regulating gastrulation, wound healing, extravasation by leukocytes and so on, are shared with both trophoblast and cancer invasion 6, 10, 11 . This implies that invading cancer cells use mechanisms that evolved much earlier than placental invasion and, therefore, the evolution of invasive placentation per se cannot be responsible for the origin of malignant cancer. It is important to note, however, that the invasiveness of the placenta continued to evolve after its origin. Placental invasion reverted to a non-invasive phenotype in several lineages of placental mammals, as well as evolving an even higher degree of invasiveness in the great apes, which includes humans [12] [13] [14] .
A complete loss of placental invasion evolved in hoofed mammals, such as cows and horses and their relatives, and these animals have lower malignancy rates for a variety of cancers 9 . In contrast, humans (with very invasive placentas) are highly vulnerable to melanoma malignancy.
On the basis of the arguments outlined above, we suggest that evolutionary changes in the permissiveness or resistance of uterine stromal cells to placental invasion are mechanistically linked to the vulnerability to cancer malignancy 9 . We term this 'Evolved Levels of Invasibility' (ELI; Fig. 1a ) and experimentally test ELI using an in vitro model (Fig. 1b ). We demonstrate that human fibroblasts are more permissive to invasion by trophoblasts, as well as cancer cells, compared to their bovine counterparts. We then identify factors responsible for the resistance to invasion, paving a way for therapeutic interventions. This study highlights how investigating evolutionary processes may lead to the identification of therapeutic targets, pointing to the clinical potential of evolutionary analysis. co-culture of stromal and invasive cells on structured adhesion substrata. This approach was validated in previous cancer-stroma interaction studies 20, 21 . The extent of invasion was measured as the average distance over which invasive cells have penetrated the stromal monolayer. The platform also enabled the sensitive measurement of cell invasion (Fig. 1c ).
We first compared the spread of malignant (1205Lu) and nonmalignant (WM35) melanoma cells into a monolayer of human skin fibroblasts (BJ5ta) on substrata reproducing the nanotopographic features of aligned ECM fibres or on flat surfaces. Aligned matrix fibres are a common feature in many tissues 22 . We found that mimicking aligned ECM matrix microenvironment allowed malignant 1205Lu melanoma cells to more extensively invade the skin fibroblast monolayer than non-malignant WM35 cells did (Fig. 1d,e and Extended Data Fig. 1a ). Furthermore, when 1205Lu and WM35 cells were compared on a flat surface, no statistically significant difference could be detected. In contrast, a significant difference between 1205Lu and WM35 was detectable in the ECM-mimetic platform ( Fig. 1e and Extended Data Fig. 1b,c) , indicating that this assay has higher sensitivity in measuring stroma invasion compared to experiments on a flat surface.
Bovine endometrial stroma is resistant to trophoblast invasion.
To explore the causes of species differences in placental invasion, we measured the invasion of a human choriocarcinoma (J3) cell line into human endometrial stromal fibroblasts (hESFs) and compared them to bovine trophoblasts (F3) invading bovine endometrial stromal fibroblasts (bESFs). At 48 h J3 cells invaded deeply into hESF layer, while the F3 invasion into bESFs was much more limited (Fig. 1f,g and Supplementary Videos). Upon closer inspection we found that human J3 cells formed invasive forks which propelled invasion into hESFs, while the bovine F3 showed no invasive forks ( Fig. 1f-h) . These results recapitulate the in vivo species differences during embryo implantation [23] [24] [25] [26] .
In human placenta, extravillous trophoblasts (EVTs) constitute the most invasive cell type 27, 28 . We therefore measured the invasion of human chorioblastoma cell line BeWo, the EVT cell line HTR8 and the bovine F3 cells invading the layer of human or bovine stromal fibroblasts in all combinations ( Fig. 2a ). BeWo cells, although being a carcinoma cell line, have been extensively used as model of human cytotrophoblast cells 29 . The results showed that, while hESF were invaded by all trophoblast cell lines, both human and bovine, bESF were more resistant to invasion (Fig. 2b ). The largest differences were found in the case of F3 invasion; with F3 invading rapidly into hESF monolayers but being nearly completely halted by bESFs. These cross-species invasion experiments confirmed that the limited invasion in bESF is, to a large extent, a property of the stroma cells rather than the trophoblast cells ( Fig. 2b) . In summary, the degree of trophoblast invasion is mostly controlled by the identity of the stromal cells rather than the invasive capacity of trophoblast cells, as assumed for ELI.
Bovine skin fibroblasts resist melanoma invasion. The findings
above leave open the possibility that the observed effects could be specific to the fetal-maternal interface rather than reflecting species differences in stromal invasibility in general. In humans, melanoma invasion into the surrounding stroma is a strong predictor of malignancy 30 . Would stromal compartments in other tissues than the uterus (for example, the skin) show similar species-dependent properties to the uterine stromal cells? To address this question, we investigated whether gene expression profiles of human and bovine skin fibroblasts are more similar to those of their corresponding endometrial fibroblasts in the same species than they are to their homologous cell type in the other species.
The null hypothesis of independent transcriptome evolution of cell types predicts that corresponding (homologous) cell types should be more similar to each other than they are to a different cell type in the same species 31 . This is because, for instance, the human and bovine lineages diverged more recently than skin and endometrial fibroblasts have differentiated in evolution. This is necessarily true because otherwise corresponding cell types would not be homologous 32 . On the other hand, if gene expression profiles in skin and endometrial fibroblasts co-evolved, the cells from the same species could be more similar than to the corresponding/homologous cell in the other species. ELI predicts that, in each species, endometrial fibroblasts and skin fibroblasts share the same level of invasion resistance because their gene expression profiles co-evolved, such that selection for higher or lower endometrial invasiveness has a parallel effect on the invasibility of skin fibroblasts. Therefore, we expect that the stromal cell types from the same species are more similar to each other than they are to corresponding cell types in the other species 33 .
To evaluate this expectation, we performed RNA sequencing on bovine and human skin fibroblasts and compared them to human and bovine endometrial fibroblasts. Principal component analysis showed that the gene expression distance between skin fibroblasts and endometrial stromal fibroblasts of the same species was less than the distance between corresponding cell types of different species ( Fig. 2c ). The observed pattern is consistent with the suggestion that gene expression in endometrial and skin fibroblasts indeed coevolved due to pleiotropic effects of mutations on transcriptional regulation 31, 33 . In other words, the biology of skin and endometrial fibroblasts can be expected to be similar within species even though they differ between species.
We then measured invasion of malignant human melanoma cells (A375) into the skin fibroblasts from human (BJ5ta) and bovine (bSkFb) and found that bSkFb indeed resisted A375 invasion more strongly than did human skin fibroblasts ( Fig. 2d ). This greater invasion resistance of bSkFb was supported by a similarly Fig. 1 | An experimental platform to test ELi. a, Illustration of ELI. Placentation in humans is haemochorial, where the placental trophoblasts invade the maternal stroma reaching the blood supply. In contrast, in cows and other boroeutherians, placentation has recently evolved to be epitheliochorial, where the trophoblast epithelium attaches to the endometrial epithelium but does not invade the maternal interstitium. The ELI suggestion is that bovine stroma has evolved to resist invasion compared to human stroma and, therefore, secondarily limits cancer metastasis. b, Illustration showing a cell-patterning nanotextured platform to quantitatively and sensitively measure collective invasion into stroma; stromal cells and invasive cells are patterned by a PDMS stencil into juxtaposed monolayers heterotypically interacting with each other, and imaged using live-cell microscopy to observe collective cell invasion into the stroma. high resistance of these cells to invasion by WM35, 1205Lu and SKMel28 melanoma cell lines ( Fig. 2e ). A similar assay with bovine melanoma cells was precluded owing to lack of bovine melanoma cell lines 34 . Overall, these results indicate that bovine skin fibroblasts can resist cell invasion better than their human counterparts can.
Human and bovine fibroblasts respond differently to trophoblast co-culture. To understand the genetic underpinnings of ELI in bovine stromal cells, we collected RNA sequencing data from human and bovine endometrial fibroblasts, with and without coculture with the respective trophoblasts. We focused on differentially expressed genes in stromal cells, both basally and upon interaction with species-specific trophoblasts. Endometrial fibroblasts of both species were labelled with DiI fluorescent stain and co-cultured with equal number of unlabelled trophoblast cells, HTR8 and F3 for human and bovine cells respectively (Extended Data Fig. 3a ). Co-cultures were maintained for 72 h and the cells were sorted using fluorescence-activated cell sorting (FACS) 20 . Henceforth, the bovine cells will be referred to as bESFs and bESF co-F3 and human cells as hESFs and hESF co-HTR8 . Many genes were differentially expressed in bovine versus human endometrial fibroblasts (Extended Data Fig. 3b ) and ESFs responded strongly to co-culture with their cognate trophoblasts cells (Extended Data Fig. c,d ). Furthermore, human and bovine ESFs responded differently to trophoblast co-culture ( Fig. 3a,b and Extended Data Fig. 3e ,f). Human and bovine endometrial stromal cells differed substantially with respect to the number of genes affected by co-culture, with human cells showing more differentially expressed genes (5,349 genes changed at P ≤ 0.01; false discovery rate, FDR = 3.1 × 10 −3 ) compared to bovine cells (3,101 genes at P ≤ 0.01; FDR = 7.01 × 10 −3 ). Gene-set analysis revealed genes belonging to chemotactic activity, cell motility and metastasis ontologies at higher relative abundance in hESF co-H8 compared to bESF co-F3 (Fig. 3b ). These results suggest that species differences in invasibility may be caused by differential gene expression among the stromal cells in response to trophoblast cells.
We found that human and bovine ESFs expressed markedly different sets of chemokine ligands ( Fig. 3c ) and chemokine receptors ( Fig. 3d ), although both were enriched in transcripts associated with angiogenesis. Genes showing elevated expression in hESFs included fibroblast growth factors, vascular endothelial growth factors, semaphorins, members of the transforming growth factor (TGF) family, as well as NRPs and ROBO1, whereas bESFs showed high expression of endothelin (END1), plasminogen activator (PLAU), thrombopoeitin (THPO) and notably, transforming growth factor β2 (TGFB2). In contrast, genes belonging to ontologies GO_adherens junction and endothelial barrier did not show systematic expression differences in favour of either hESF or bESF (Extended Data Fig. 4a,b) . Finally, the genes related to GO_fibroblast migration tend to be expressed at lower levels in bESF versus hESF (Extended Data Fig. 4c ). These data point to the possibility that stromal response to trophoblast co-culture varies strongly between the species for genes that could play a role in the interaction between invading trophoblast cells and stromal cells, as opposed to genes that regulate basal stromal integrity. Differential expression of these genes may affect the invasibility phenotype in either species. These analyses suggested that differences in the interactions between the stromal and invading cells were drivers of ELI in human and bovine. For instance, transforming growth factor β (TGF-β) and WNT signalling pathways are mediators of cancer stromal interaction [35] [36] [37] [38] [39] [40] and thus we explored the effect of trophoblast co-culture on the activation of these signalling pathways to see whether there are parallels between cancer-stroma and trophoblast-endometrial stroma interactions. Expression of genes in non-canonical WNT and TGF-β pathways were indeed higher in FGF5  NRG1  LIF  EDN1  BDNF  CTGF  C3  PLAU  SBDS  FGF18  PDFGRL  INHBA  HBEGF  TNFRSF11B  BOK  THPO  ADM2  SEMA4G CAT BMPR1A  ACVR2A  ANGPTL4  ESR1  NPR3  IL20RB  IL10RB  FLT1  TNFRSF21  IL27RA  TGFBR2  PTGFR  NR2F1  NR1D1  IFNAR2  IL7R  PLAUR  NR1D2  TNFRSF6B  IL13RA1  MET  PGF  SDC1  TEK  S1PR1  CRIM1  PTGER4  NR3C1  NRP2  IL6R  NRP1  ROBO1  AR  FGFRL1  SDC2  IGF2R  PLXNA2  IL1R1  IL1RAP LGR4 hESFs compared with bESFs ( Fig. 3e ,f). Ingenuity pathway analysis showed that both signalling pathways were differentially activated in bovine and human ESFs (Extended Data Fig. 4e ). Although coculture with trophoblasts resulted in reduction in expression of genes belonging to TGF-β pathway for hESFs, they continued to remain many times higher when compared in bESFs. While TGF ligands TGF-β1 and TGF-β3 as well as receptors of the TGF-β family (for example, ACVR1) were highly expressed in hESFs, negative regulators like TGF-β2 and inhibin-A were expressed at higher levels in bESFs. Similarly, we observed that downstream transcription factors SMAD-2, -3 and -5, as well as the co-SMAD, SMAD4, were expressed at higher levels in hESFs compared to bESFs (Fig. 3e) .
Similarly, many members of the WNT signalling network showed higher expression in hESF versus bESF ( Fig. 3f and Extended Data Fig. 4d ). These results supported a role for paracrine signalling between heterotypic cells during the invasion processes in both the uterus and in tumour lesion, prompting us to further explore the role of the signalling networks in stromal invasion.
Selected gene knockdown in human fibroblasts increases resistance to melanoma invasion.
We hypothesized that modulating the differentially expressed genes in human stromal cells could induce them to become more resistant to invasion in human cells. We focused on genes related to WNT and TGF-β signalling. Specifically, we selected 16 genes from the TGF-β and WNT pathways that had higher expression in hESF or were upregulated in hESF in co-culture with trophoblast cells (Fig. 4a ). We then targeted these genes using a battery of small interfering RNAs (siRNAs) in hESFs and BJ5ta to test whether they could modulate stromal invasibility. Comparison of each siRNA-transfected stromal cell population was made with appropriate untransfected controls, as well as with cells transfected with control non-targeting siRNA (Extended Data Fig. 5a,b ). HTR8 invasion into hESF was significantly reduced after 24 h in eight out of 16 genes (Fig. 4b ). A375 invasion into BJ5ta skin fibroblast monolayer was observed for 18 h and 36 h after gene knockdown. Nine of these gene knockdowns significantly decreased invasion into the skin fibroblast monolayer (Fig. 4c ), including members of WNT superfamily, TGF-β ligands, as well as less-established targets and effectors of WNT signalling, for example STARD7 (ref. 41 ), LPIN1 (refs. [42] [43] [44] [45] [46] ) and YAP1 (ref. 47 ). Furthermore, we detected a weak but significant correlation in the increase of stromal resistance to invasion following gene knockdowns in both hESF and BJ5ta (R 2 = 0.25, P = 0.02), indicating that gene silencing enhances resistance to invasion in a similar manner in both human endometrial and skin fibroblasts ( Fig. 4d ). Moreover, the average response for all gene knockdowns was an increase in resistance to invasion (Fig. 4e) . These results suggested that human skin fibroblasts could be induced to resist melanoma invasion and that knowledge of gene expression in cow fibroblasts can tell us how to achieve this.
Opposite evolutionary trends of vulnerability to malignancy in humans and bovines.
To assess the evolutionary history of the expression of the genes identified above as important for ELI, we cultured the ESFs from rabbit, rat, guinea pig, cat, horse and sheep to extend our analysis ( Fig. 4f ). This taxon sample represents two clades of eutherian mammals, the Euarchontoglires and the Laurasiatheria, together forming the clade of Boreoeutheria. We plotted the phylogenetic tree of these eight species 48 , along with the expression of these genes in skin fibroblasts compared to the inferred boreoeutherian ancestor (√TPM species − √TPM ancestor , where TPM is transcripts per million).
We found, surprisingly, that humans evolved higher expression levels of invasibility enhancing genes (TGFB1, ACVR1, DDR2, LPIN1, CD44, MMP1), compared to the inferred boreoeutherian ancestor. The expression levels of these genes in human skin fibroblasts is higher than that of rabbit, rat and guinea pig. All of these species have haemochorial placentation and, thus, the higher expression level of these genes in humans probably evolved in the primate lineage. The limited data on a selected group of genes, therefore, supports ELI amongst mammals and points to the possibility of increased stromal vulnerability in humans and decreased stromal vulnerability in bovines.
Discussion
Mammalian species differ in their potential for tumourigenesis, as well as their vulnerability to cancer metastasis 9, 49 . The comparative biology of cancer incidence across different animals has identified species-specific tumour suppressor mechanisms explaining the variation in occurrence of tumours between species [50] [51] [52] [53] [54] [55] . In a recent review, Constanzo and collaborators made a convincing case for a model where cancer progression in humans includes the reactivation of embryonic gene expression normally controlling placenta development and immune evasion 56 . Here, we focus on differences across species in the rates of cancer malignancy rather than differences in rates of tumourigenesis. For instance, melanoma does occur in bovines and equines but remains largely benign [57] [58] [59] ; while it is highly malignant in humans. This correlates with the phenotype of the fetal-maternal interface (the degree of placental invasion during pregnancy).
In human stromal fibroblasts, siRNA-guided knockdown revealed genes that impart stromal invasibility by melanoma and trophoblast cells (Fig. 4g ). These genes include TGF-β ligands, consistent with results from colorectal cancer 38 . Other genes enhancing stromal invasibility are members of the non-canonical WNT pathway, as well as WNT signalling modulators (for example, LPIN1, ref. 60 ), by directly regulating β-catenin levels (for example, YAP/TAZ, ref. 47 ) or by being regulated by β-catenin-induced transcription (for example, CD44, ref. 61 ). Of these, YAP1, a Hippo signalling pathway target promoting tumour growth 62 , can also be regulated by non-canonical WNT signalling and can, in turn, inhibit canonical WNT signalling 47 . Both TGF-β 63, 64 and non-canonical WNT signalling 65, 66 are known to affect tumour progression and metastasis. TGF-β1 and TGF-β3, expressed at relatively higher levels in hESF, are also reported to regulate β-catenin activity, indicating that human stromal vulnerability to invasion may be influenced by paracrine signalling to invading cells through secreted ligands. Also of interest, many of the genes identified in our comparative gene expression screen have connections to metabolic regulation. These include genes encoding LIPIN1, which regulates triglyceride metabolism 67 , and MGAT5, known to regulate glucose uptake in tumour cells 68 .
The results presented here show that species differences in malignancy rates may, in part, be caused by species differences in invasibility of stromal cells. We found that bovine stroma evolved lower invasibility probably via decreased paracrine signalling through TGF-β and WNT pathways. In particular, these results argue that TGF-β secretion and high non-canonical WNT signalling in stromal cells are causal factors explaining the high vulnerability of human stromal tissues to cancer invasion, at least in the case of melanoma. Comparative transcriptomic data across multiple additional species further suggests that the human lineage evolved higher expression of these genes enhancing tumour and trophoblast invasion and, thus, probably has evolved higher malignancy rates than in the common ancestor of boreoeutherian mammals.
Our data support the ELI hypothesis, suggesting that differences in stromal gene expression between species are causal in determining the degree of embryo implantation as well as stromal resistance to early cancer dissemination. In Eutheria epitheliochorial placentation has evolved several times from the pre-existing invasive placentation, suggesting that evolutionary advantages of noninvasive placentation [12] [13] [14] may drive corresponding differences in malignancy resistance. We further found that apes may also have evolved increased stromal receptivity to trophoblast invasion and 
correlatively have evolved higher vulnerability to cancer malignancy. As EVTs have evolved recently in great apes, the endometrial stroma may also have increased invasibility to accommodate the more invasive trophoblast types 69 . Our ELI hypothesis, and its experimental validation, suggest that studying the genetic basis for evolved resistance to invasion can identify factors determining the stromal control of cancer progression and identify therapeutic targets.
Methods
Cell sourcing. The study used a variety of cell sources for comparative analyses. Human ESFs were immortalized by the Charles Lockwood laboratory and obtained from Gil Mor group 70 . The F3 cells were previously established by Pfarrer's group 71, 72 . The J3, HTR8/SVNeo, BeWo and BJ5ta cells were obtained from ATCC. Skin fibroblasts bSkFb bovine (Bos taurus), as well as those from guinea pig (Cavia porcellus), sheep (Ovis aries), pig (Sus scrofa) and rabbit (Oryctolagus cuniculus) were obtained from fresh skin tissue. A small piece of skin was collected, hair removed and the sample was washed in PBS buffer and cut into strips approximately 1.0 cm 2 . Dermis was separated from epidermis by enzymatic digestion (30 min in 0.25% Trypsin buffer at 37 °C, followed by dissociation buffer (1 mg ml -1 collagenase, 1 mg ml -1 Dispase, 400 μg ml -1 DNase I) for 45 min at 37 °C). Epidermis was removed and 2 mm pieces were cut from the dermis and transferred to a 12-well plate and covered with media. Fibroblasts emerged from the explants and grew to confluency in growth media. Extra tissue was removed and cells were subcultured a few times using a cell scraper.
Bovine ESFs were obtained as follows. Uterine tissues were collected from each species and primary ESF were obtained by enzymatic digestion. Uterus fragments, 2-3 mm in size, were created using a scalpel and digested with 0.25% Trypsin-EDTA for 35 min at 37 °C, followed by dissociation buffer (1 mg ml -1 collagenase, 1 mg ml -1 Dispase, 400 μg ml -1 DNase I) for 45 min at 37 °C. Cell clumps were homogenized by passage through a 22-gauge syringe followed by passage through a 40-μm nylon mesh filter to remove remaining clumps. A single-cell suspension was obtained from the lysate, transferred to fresh growth medium and cultured in T25 flasks. To facilitate enrichment of fibroblasts versus epithelial cells, media were exchanged in each well after 15 min to remove floating cells that had not yet attached while stromal fibroblasts had attached. Cells were grown to confluency and sub-passaged by scraping the cells off the surface to be split into two T25 flasks. At confluency, cells were split through one more round of differential attachment. We used immunohistochemistry to test for abundance of vimentin (Santa Cruz, sc-6260) and cytokeratin (Abcam, ab9377) to validate fibroblast subtype in the isolated cells.
Isolates of hESF, bSkFb and bESFs were tested for potential mycoplasma contamination and were found to be free from it.
Cell culture. Human ESFs were grown in phenol-red free DMEM/F12 with high glucose (25 mM), supplemented with 10% charcoal-stripped calf serum (Hyclone) and 1% antibiotic/antimycotic (Gibco). Decidualization was induced in ESFs with 0.5 mM of 8-Br-cAMP (Sigma) and 0.5 mM of progesterone analogue medroxyprogesterone acetate for 96 h in DMEM supplemented with 2% charcoal-stripped calf serum (Hyclone). BJ5ta (ATCC) cells were cultured in 80% DMEM and 20% MEM supplemented with 10% FBS, 1% antibiotic/antimycotic and 0.01 mg ml -1 hygromycin. F3 cells were obtained from Pfarrer's group and were cultured in DMEM with high glucose supplemented with 10% FBS, 1% antibiotic/antimycotic (Gibco). J3 cells were cultured in αMEM supplemented with 10% FBS, 1% antibiotic/antimycotic (Gibco), while HTR8/SVNeo (ATCC) were cultured in RPMI-1640 supplemented with 10% FBS and 1% antibiotic/antimycotic (Gibco).
Fabrication of polyurethane acrylate mould.
Photoresist was spin-coated on silicon wafers and electron-beam lithography was used to nanopattern the wafers (JBX-9300FS, JEOL). After the photoresist was developed, exposed silicon was etched by deep-reactive ion etcher (STS ICP Etcher) resulting in formation of submicrometre parallel ridges. Residual photoresist was removed using ashing and diced into silica masters for subsequent replica moulding.
Ultraviolet (UV) curable polyurethane (PUA) was dropwise dispensed onto the silicon master previously prepared and contacted with polyethylene terephthalate (PET) film. Application of UV light (wavelength λ = 200-400 nm, 100 mJ cm -2 ) for 1 min was used to cure PUA, after which the mould was peeled off with tweezers and cured overnight under UV light to terminate the residual acrylate groups. The process resulted in a PUA mould of ~50 μm thickness.
Fabrication of nanotextured substrate. Previously prepared PET mould was used as a replica mould to transfer the topographic pattern onto glass substrate using the technique of capillary force lithography. Briefly, glass substrate was cleaned using NaOH (0.1 M for 1 h), washed with deionized water and dried under N 2 stream. Primer (phosphoric acrylate and propylene glycol monomethyl ether acetate in a ratio of 1:10) was spin-coated on the coverslip as a thin layer and baked for 20-30 min at 70 °C. Then 150 μl of PEG-DA (molecular weight = 575) precursor was dispensed dropwise onto the primed coverslip and the PET mould was placed reversibly. After the PUA precursor filled the submicrometre cavities by capillary action, the substrate was cured in UV light (λ = 250-400 nm, 100 mJ cm -2 ) for 1 min. The mould was peeled after polymerization using tweezers. The substrate resultant from the method consisted of nanotextured grooves with an expected elastic modulus of ~70 MPa. The substrate was cured again for 1 h under UV light to terminate residual active acrylate groups.
Cell patterning for stromal invasion assay. For cell patterning, we used a stereolithographic plastic mould to create a polydimethylsiloxane (PDMS) stencil. The PDMS stencil was cast by mixing monomer and cross-linker in a ratio of 10:1 and cured at 80 °C for 4 h by placing it on a predesigned plastic mould. Stencils were washed using isopropyl alcohol and dried using N 2 stream, placed on the nanotopographic substrate coated with laminin (25 μg ml -1 ) and the device kept in a vacuum to allow air under the stencil to be removed to avoid chance of leakage. DiI-labelled invasive cells were seeded onto the stencil at a density of 10 6 cells per 100 μl and allowed to attach and polarize for 8 h. Unattached cells were washed off twice with PBS and the stencil removed carefully using blunt-end tweezers. Unlabelled stromal cells were seeded at a density of 10 6 cells per 100 μl to attach to the area previously covered by PDMS stencil. After 6 h of attachment, unattached cells were washed off and the substrate mounted for live-cell microscopy. To ensure selection of definitive fibroblasts, and to avoid selection of trophoblasts taking up dye from dead stromal cells and occasional heterotypic cell-fusion events, we only collected DiI high cells. All experiments were conducted in similar culture conditions by 1:1 mixture of the media in either comparable conditions. Live-cell fluorescence microscopy. Phase-contrast and epifluorescence microscopy was performed using a Leica DMi8 model, with an HC PL Fluotar ×10, 0.30 dry objective and images were acquired using Leica LASX Software and processed using Fiji image analysis software. Lumencor SpectraX was used as a source of light for excitation and routed through a rhodamine excitation filter cube consisting of excitation 546 nm per 10 nm (band-pass filter), dichroic 560 nm (long-pass filter) and emission 585 nm per 40 nm (band-pass filter) and acquired using an Andor EMCCD iXon Ultra 888 camera.
Invasion analysis. Acquired sequential images for each condition were analysed using Fiji image analysis software after contrast enhancement. DiI-labelled invasive cell fronts (trophoblasts or melanoma cells) were identified manually for each time point. Area occupied by DiI-positive cells was measured at each time point. Total invasion was calculated as follows:
Extent of invasion per unit measurement of interface was determined by dividing δArea by the length of initial intercellular interface: hδArea t ð Þi ¼ δAreaðtÞ LðinterfaceÞ
Fluorescence-assisted flow sorting. Cells were detached from the substrate using TrypLE solution (Gibco), quenched with excess medium and washed thrice with PBS. Isolated cells were suspended in 1% AlbuMAX (Gibco) dissolved in PBS and sorted using FACS. FACS was performed using BD FacsARIA II using PE.Cy5 channel and analysis performed using FACSDiva v.6.0. To increase the purity of ESFs collected after the co-culture experiments and to account for possible uptake of dye from dead or dying stromal cells by the trophoblasts, as well as for occasional cell-fusion events, we only sorted DiI hi cells. Sorted cells were collected directly in RNASelect to limit RNA degradation. Even cells that were not in co-culture were subjected to the same sorting protocol. siRNA transfection and characterization. For gene-silencing experiments, stromal cells (BJ5ta or hESFs) were cultured in 12-well plates and transfected with at least two siRNAs (shown in Table 1 ) at a concentration of 50 nmol per well. Lipofactamine RNAiMAX was used to transfect siRNAs obtained from Integrated DNA Technologies (IDT).
RNA isolation and qRT-PCR.
RNA was isolated using RNeasy micro kit (QIAGEN) and resuspended in 10 μl of water. SuperScript IV VILO Master Mix (ThermoFisher) was used to synthesize cDNA from 1 µg of mRNA and ezDNase was used to remove DNA after reverse transcription. Primers from IDT were used for qRT-PCR reaction using SybrGreen (ThermoFisher) to evaluate the efficiency of siRNA-mediated knockdown. B2M and RPL0 were used as internal reference genes and both were found to be consistent within samples after knockdown. Quantitative RT-PCR was performed in Quantstudio3 (ThermoFisher) and relative quantitation was performed by comparative cycle number, C t .
RNA sequencing. Agilent Bioanalyzer 2100 was used to determine RNA quality and RNA integrity number (RIN) of over 8 was observed in the samples. TruSeq RNA Library from Illumina was used to prepare mRNA library. These libraries were sequenced on Illumina HiSeq to generate 30-40 million reads per sample (Single-end 75 base pair reads) and a high Q score was observed (Q > 30) for the sequenced data. Alignment of reads and gene-specific analysis was performed in
Partek Flow software v.5.0. Human cells data were aligned to reference genome (hg38) using STAR alignment (in Partek Flow) and bovine data were aligned using Bos Taurus assembly UMD_3.1.1/bosTau8. Quantification was performed using quantify to annotation model (Partek E/M) using Ensemble Transcripts release 85 (humans) or Ensemble-UMD3.1 gene annotation model. Normalization was performed using TPM 73 . Gene-level comparison and statistical analysis was performed using analysis of variance and significance of (adjusted) P = 0.05 or less was considered for analysis. Gene lists comparison was performed by obtaining ontology/pathway specific list from Gene Ontology 74 or Kyoto Encyclopedia of Genes and Genomes (KEGG 75 ).
Comparative transcriptome analysis. Raw sequence reads (single-ended 75 base pairs) for ESFs from rabbit (Oryctolagus cuniculus), rat (Rattus norvegicus), guinea pig (Cavia procellus), cat (Felis catus), horse (Equus caballus) and sheep (Ovis aries) were aligned to reference genome assemblies OryCun2.0, Rnor_6.0, Cavpor3.0, Felis_catus_8.0, Equcab2 and Oar_v3.1, respectively, using Tophat2 (v.2.1.1). Read counts for all genes were calculated using HTSeq (v.0.6.1p1, https://htseq. readthedocs.io/en/release_0.11.1/index.html) with Python (v.2.7) according to Ensembl gene annotation release 92 (horse) or release 89 (other species). Then TPM were calculated to estimate relative mRNA abundance 73 . To make gene expression levels comparable across species, we further normalized TPMs such that one-to-one orthologues have the same sum across species. The orthologue tables in this analysis were downloaded from Ensembl using BioMart tool. The ancestral state reconstruction for gene expression was performed on √TPM using function 'ace' from R package ' APE' 76, 77 .
Two genes that have been found to influence invasibility in our knock down experiments (Fig. 4b,c ), YAP1 and MMP1, have one-to-many or no orthologues in some species in our analysis. YAP1 has two orthologues in cow, ENSBTAG00000039307 (TPM = 183.4) and ENSBTAG00000047406 (TPM = 96.3) and no orthologue in guinea pig. MMP1 has two orthologues in cow, ENSBTAG00000015818 (TPM = 0.053) and ENSBTAG00000048029 (TPM = 0.645) and three orthologues in rat, ENSRNOG00000055895 (TPM = 0), ENSRNOG00000008881 (TPM = 0.157) and ENSRNOG00000032353 (TPM = 0.698). In these cases, the orthologues with the highest TPM were used to perform the ancestral state reconstruction.
Reporting Summary. Further information on research design is available in the Nature Research Reporting Summary linked to this article.
Data availability
Data for the human-cow transcriptome comparison with and without co-culture with trophoblast cells are available under GSE136299 in the Gene Expression Omnibus (GEO) database of NCBI, https://www.ncbi.nlm.nih.gov/geo/. The comparative fibroblast gene expression data are available under PRJNA564062 under SUB6229748 and SUB6264591 on the Sequence Read Archive (SRA) of NCBI, https://www.ncbi.nlm.nih.gov/sra.
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